Self-sealing syringe prevents blood loss in hemophilic mice

October 28, 2016 by Heather Zeiger, Phys.org report

Preparation of a needle with self-sealing puncture properties and images of the needle coated with CHI-C film (SEM image). Credit: (c) Nature Materials (2016). DOI: 10.1038/nmat4758
(Phys.org)—For people whose blood does not clot appropriately, such as those with hemophilia, diabetes, or cancer, getting an injection or blood draw with a hypodermic needle is not a trivial matter. Because the needle punctures the patient, this can result in continuous bleeding and risk of blood-borne infection. While researchers have looked at alternative methods, syringe injections are still the best method for rapid drug delivery. One solution could be a self-sealing syringe.

Researchers hailing from several institutions in the Republic of Korea have demonstrated that a syringe coated with a partially crosslinked catechol-functionalized chitosan thin film can successfully seal a puncture wound in . Furthermore, in mice and rabbits with hemophilia, their preliminary tests showed a 100% survival rate after injection. Their work appears in Nature Materials.

Shin et al. wanted a self-sealing coating for a hypodermic syringe that would not delaminate upon injection, but would upon removal of the syringe so that it would seal the puncture site. Inspired by the water-resistant secretions of mussels, they developed a catechol-functionalized chitosan polymer that can change from a thin film to a gel-like material when it comes in contact with blood plasma. They were able to make a homogeneous coating on syringe needles of varying gauges.

To test their concept, Shin et al. evaluated the technique with three different sets of mice. The first set of mice was punctured in the saphenous vein using a coated syringe in which the polymer had been pre-incubated for three days. The second set of mice was injected with a syringe without coating, and the third set of mice was injected with a syringe with coating that was not pre-incubated.

The mice that were injected with the pre-incubated syringe demonstrated no blood loss, while the bare syringe demonstrated the most blood loss. The non-incubated syringe evidenced delamination upon entry.

The incubation period results in the oxidation of some of the catechol (approx. 5.4%) to quinone, which serves to strengthen the polymer coating. In vitro viscosity tests showed that the non-incubated polymer did not change from a solid film to a gel-like material, but converted to a sol-phase, which resulted in film tearing. The incubated polymer underwent enough partial oxidation that upon exposure to human plasma, it converted to a more mechanically robust gel.

Their rabbit studies used a needle gauge of 23 G, which is the upper end of the size range used in humans. For these studies, Shin et al. looked at blood vessel morphology and evidence of polymer on the blood vessels. They also looked at coagulation time and changes in blood factor levels. They found that there was no appreciable blood loss in the rabbits tested and the hemostatic needle did not affect blood coagulation factors. Complete blood count was used to make sure that there was no evidence of reaction to foreign material.

These two tests provide a proof-of-principle for the self-sealing abilities of a hemostatic needle. The next step was to test mice with . Hemophilic mice were injected in the jugular vein using either the polymer-coated hemostatic needle or a bare needle. All of the hemophilic mice that were injected with the hemostatic needle survived while the others did not. Shin et al. obtained similar results with other injection sites (e.g., intermuscular injections).

This promising research opens the door for a way that those with anticoagulating diseases can have the advantages offered by syringe injection and blood draw without the risks associated with an open wound. Future research could involve using this polymer coating in other medical devices.

Explore further: WHO calls for 'smart' syringes to stem deadly diseases

More information: Mikyung Shin et al. Complete prevention of blood loss with self-sealing haemostatic needles, Nature Materials (2016). DOI: 10.1038/nmat4758

Abstract
Bleeding is largely unavoidable following syringe needle puncture of biological tissues and, while inconvenient, this typically causes little or no harm in healthy individuals. However, there are certain circumstances where syringe injections can have more significant side effects, such as uncontrolled bleeding in those with haemophilia, coagulopathy, or the transmission of infectious diseases through contaminated blood. Herein, we present a haemostatic hypodermic needle able to prevent bleeding following tissue puncture. The surface of the needle is coated with partially crosslinked catechol-functionalized chitosan that undergoes a solid-to-gel phase transition in situ to seal punctured tissues. Testing the capabilities of these haemostatic needles, we report complete prevention of blood loss following intravenous and intramuscular injections in animal models, and 100% survival in haemophiliac mice following syringe puncture of the jugular vein. Such self-sealing haemostatic needles and adhesive coatings may therefore help to prevent complications associated with bleeding in more clinical settings.

Related Stories

WHO calls for 'smart' syringes to stem deadly diseases

February 23, 2015

The World Health Organization has called on healthcare providers around the globe to switch to syringes that can only be used once in order to better battle deadly diseases spread by needle sharing.

Skin patch could replace the syringe for disease diagnosis

October 22, 2014

Drawing blood and testing it is standard practice for many medical diagnostics. As a less painful alternative, scientists are developing skin patches that could one day replace the syringe. In the ACS journal Analytical Chemistry, ...

Mass. Senate debates needle law

May 2, 2006

Massachusetts state senators are debating a bill that would legalize over-the-counter sales of hypodermic needles.

Researchers develop new way to manufacture nanofibers

May 13, 2015

Researchers at the University of Georgia have developed an inexpensive way to manufacture extraordinarily thin polymer strings commonly known as nanofibers. These polymers can be made from natural materials like proteins ...

Nanopatch to help WHO battle polio

September 17, 2014

The World Health Organisation's (WHO) battle against polio has a new weapon after joining forces with Vaxxas, the biotechnology company responsible for developing revolutionary vaccine delivery method the Nanopatch.

Slow-release 'jelly' delivers peptide drugs better

January 28, 2013

Duke University biomedical engineers have developed a new delivery system that overcomes the shortcomings of a promising class of peptide drugs – very small proteins – for treating diseases such as diabetes and cancer.

Recommended for you

Fish-inspired material changes color using nanocolumns

March 20, 2019

Inspired by the flashing colors of the neon tetra fish, researchers have developed a technique for changing the color of a material by manipulating the orientation of nanostructured columns in the material.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.